...
机译:肿瘤渗透CD63阳性细胞对胶质母细胞瘤多形患者存活的影响
Faculty of Medicine University of Tartu Tartu Estonia;
Faculty of Medicine University of Tartu Tartu Estonia;
Faculty of Medicine University of Tartu Tartu Estonia;
Faculty of Medicine University of Tartu Tartu Estonia;
Department of Radiotherapy and Oncological Therapy Hematology and Oncology Clinic Tartu University;
Department of Radiotherapy and Oncological Therapy Hematology and Oncology Clinic Tartu University;
Faculty of Medicine University of Tartu Tartu Estonia;
Faculty of Medicine University of Tartu Tartu Estonia;
Glioblastoma; Inflammation; Immune system; Radiotherapy; Survival;
机译:肿瘤渗透CD63阳性细胞对胶质母细胞瘤多形患者存活的影响
机译:胶质母细胞瘤患者肿瘤浸润淋巴细胞中FoxP3 +调节性T细胞的比例增加与肿瘤复发和生存期降低有关
机译:尽管在肿瘤微环境和系统水平上存在综合免疫抑制机制,但胶质母细胞瘤患者CD3 +和CD8 +肿瘤浸润免疫细胞的升高与存活时间延长相关
机译:空间距离测量法预测多形性胶质母细胞瘤患者的生存时间
机译:患者匹配的正常和肿瘤aCGH谱的广义奇异值分解(GSVD)比较显示出预测胶质母细胞瘤多形体存活的总体拷贝数变化。
机译:CD133阳性干细胞比例对多形性胶质母细胞瘤患者生存的影响
机译:PD-0527:CD63阳性炎症细胞对多形性胶质母细胞瘤患者生存的影响